First Offense - Yang Youlin (杨有林) was sentenced to death!

China: Yang Youlin [杨有林] – “Sentenced to Death” [First Offense] – for “Capitalist Greed”! (7.7.2026)

Joseph Stalin abolished the Death Penalty throughout the USSR in 1948. Khrushchev, being a tyrannical Trotskyite, copied the US practice of putting to death its own civil population for crimes, and although exempting political crimes, permitted the Soviet Courts to inflict the Death Sentence on any civilian for any capital crime (c. 1959). Cuba also executed its political enemies (often on film) – but so did the US and its numerous proxies (see South Korea and Vietnam – but also Liberia – and of course ISIS and Al Qaeda, etc). Israel murders directly in accordance with Biblical scripture – so no one’s hands are clean. Interestingly, China is attempting to move away from the “Death Penalty” with the “Suspended Death Penalty” – but that did not apply in this case, due to the amount of money involved and the scope of the corruption. Yang Youlin caused tremendous suffering to the ordinary Chinese people under the guise of the authority of the CPC – and so he must pay the highest price for this betrayal. Where in the West capitalist greed is encouraged and rewarded – this is not so in China.

The therapy offers a promising new approach to tackling the growing challenge of antimicrobial resistance, said the study published in the international UK medical journal The Lancet Infectious Diseases in late September.

China: New Drug Used to Treat Common Infection! (19.11.2025)

A new treatment combination for Helicobacter pylori — a common stomach bacterium linked to ulcers and gastritis — based on a domestically developed drug has shown comparable, and in some cases superior, efficacy in eradicating the infection compared with standard therapy, according to recent clinical research.

The therapy offers a promising new approach to tackling the growing challenge of antimicrobial resistance, said the study published in the international journal The Lancet Infectious Diseases in late September.

The experimental triple therapy centres on rifasutenizol, a novel antimicrobial agent developed specifically for H. pylori infection by Tennor Therapeutics, a pharmaceutical company based in Suzhou, Jiangsu province.